Skip to main content

Advertisement

Table 4 Cause-specific mortality in IgA anti-tTG positive individuals

From: Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III

Follow-up tTGA+ Deaths tTGA- Deaths Adjusted HR; 95 % CI P value Absolute risk/1000 PYAR Excess risk/1000 PYAR
Cardiovascular 21 1372 1.10; 0.72–1.70 0.653 27 2
Cancer 13 662 1.48; 0.85–2.56 0.164 16 5
Respiratory 11 180 5.11; 2.76–9.46 <0.001 14 11
Other 13 743 1.30; 0.75–2.25 0.351 16 4
  1. Reference is general population comparator cohort
  2. tTGA tissue transglutaminase antibody, PYAR Person-years at risk